NorthRock Partners’s AtriCure ATRC Stock Holding History

NorthRock Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,556	Closed	-$234K	–	308
2022 Q1	$234K	Buy	3,556 +20	+0.6%	+$1.3K	0.02%	292
2021 Q4	$246K	Hold	3,536	–	–	0.02%	277
2021 Q3	$246K	Buy	3,536 +43	+1%	+$3.31K	0.02%	242
2021 Q2	$277K	Sell	3,493 -25	-0.7%	-$1.82K	0.02%	201
2021 Q1	$230K	Buy	+3,518	New	+$217K	0.02%	206
2019 Q1	–	Sell	-13,260	Closed	-$406K	–	93
2018 Q4	$406K	Buy	+13,260	New	+$413K	0.12%	50

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NorthRock Partners's ATRC Position: Q2 2022 in Review

NorthRock Partners sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 3,556 shares — an estimated $234K sold.

NorthRock Partners first reported a position in ATRC in Q4 2018 and held it in 6 quarters. The position peaked at $406K in Q4 2018. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

NorthRock Partners reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
NorthRock Partners sold 3,556 AtriCure shares in Q2 2022, an estimated $234K.
NorthRock Partners first reported a position in AtriCure in Q4 2018 and held it in 6 quarters.
NorthRock Partners's AtriCure position peaked at $406K in Q4 2018.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on NorthRock Partners's 13F filing for Q2 2022, filed 4 Aug 2022.